Unlock instant, AI-driven research and patent intelligence for your innovation.

Methods of inhibiting cataracts and presbyopia

A technology for cataracts and presbyopia, applied in electrotherapy, pharmaceutical formulations, medical devices, etc.

Active Publication Date: 2015-12-30
UNIV OF MASSACHUSETTS
View PDF15 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Continuous supply of alpha-crystallin to the lens is a challenge

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Methods of inhibiting cataracts and presbyopia
  • Methods of inhibiting cataracts and presbyopia
  • Methods of inhibiting cataracts and presbyopia

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0074] Example 1: Cloning of γ-crystallin

[0075] [gamma]D- and [gamma]S-crystallin DNA sequences are in the pQe1 plasmid provided by the King laboratory at the Massachusetts Institute of Technology (Cambridge, MA). For purification purposes, the γ-crystallin protein sequence contains a 6×N-terminal histidine tag (His tag). This plasmid was transformed into a clonal competent cell line to create additional plasmid DNA. The plasmid was subsequently transformed into an expression competent cell line (TAM1 E. coli cells (ActiveMotif. Carlsbad, CA)) for protein synthesis.

[0076] Chemical transformation of γ-crystallin DNA into M15pRep E. coli cells for protein synthesis. Grow 1 L of culture for protein purification. The gamma-crystallin protein was purified by Ni affinity chromatography. The N-terminal His-tag contained on the γ-crystallin protein binds preferentially to the Ni column. Bound protein can be eluted using an imidazole gradient that competitively binds to Ni, ...

Embodiment 2

[0077] Example 2: Effect of pH and salt on purified γD- and γS-crystallin

[0078] Since pH and salt affect the aggregation of β-crystallin, the effect of pH and salt on γ-crystallin was also investigated. Particle size was measured using dynamic light scattering (DLS).

[0079] Experimental dynamic light scattering (DLS) was measured using an ALV goniometer with an ALV-5000 / E correlator equipped with 288 channels (ALV, Langen, Germany) and a 2W argon laser (Coherent Inc., Santa Clara ,CA), with an operating power of approximately 40mW. at angles between 30° and 90° at intervals of 5° (corresponding to 8.41×10 6 to 2.30×10 7 m -1 The scattered wave vector (q) range between) measures the scattered intensity. The scattered wave vector is defined as q=4πnsin(θ / 2) / λ, where θ is the scattering angle, and λ=514.5, the wavelength of the argon laser in vacuum, and n is 1.33, the refractive index of water. The temperature of the sample was maintained at a constant temperature of ...

Embodiment 3

[0108] Example 3 - Chemical modification of γD- and γS-crystallin with PEG24

[0109] The first modification of γ-crystallin was performed using NHSPEG24. Amino acids containing primary amines, lysine, and arginine can undergo nucleophilic substitution on N-hydroxysuccinimide (NHS)-functionalized polyethylene glycol (PEG). NHS is the active ester to promote the Sn2 reaction mechanism because it is a good leaving group. Nucleophilic substitution yields proteins modified with PEG or pegylated γ-crystallin. Pegylation was chosen because it has been shown that modifying proteins with PEG to increase solubility does not affect three-dimensional structure or properties. Specifically, PEG24 was chosen because of its reasonable molecular weight (1100.39) and spacer arm length (8.82 nm) for the added PEG24.

[0110]

[0111] NHSPEG24

[0112] Modification of γ-crystallin with PEG24 was successful, as evidenced by the large increase in the molecular weight of γ-crystallin observe...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Molecular weightaaaaaaaaaa
Molecular weightaaaaaaaaaa
Relative strengthaaaaaaaaaa
Login to View More

Abstract

Described herein are methods of inhibiting or reversing the progression of cataract formation or presbyopia in an eye by administering a gamma-crystallin charge masking agent. Both presbyopia and cataracts are caused by aggregation of the soluble crystalline lens proteins called the crystallins.

Description

technical field [0001] The present disclosure relates to methods of inhibiting or reversing the progression of agerelated changes in the lens of an eye. Background technique [0002] The lens of the eye is a transparent structure suspended directly behind the iris, which causes light to focus on the retina. The lens contains soluble and insoluble proteins; together they make up 35% of the wet weight of the lens. In a young healthy lens, soluble proteins, generally known as crystallins, make up 90% of the crystallins. During the aging process, crystallins form insoluble aggregates that account, at least in part, for the reduced deformability of the lens nucleus, which is characteristic of presbyopia, the loss of the eye's ability to change focus to see near objects. The formation of lensin-insoluble aggregates in presbyopia is considered an early stage of age-related cataract formation. [0003] Cataracts are defined by cloudiness or opacification in the lens of the eye. ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/195A61K31/22A61K31/765A61P27/10A61P27/12A61P25/16A61P25/28A61P25/00
CPCA61K31/20A61K31/4015A61K31/765A61P27/10A61K9/0048A61K31/195A61K31/4188A61P25/00A61P25/14A61P25/16A61P25/28A61P27/02A61P27/06A61P27/12A61M37/0092A61N1/325A61M2037/0007A61K9/06
Inventor 穆鲁加潘·穆图库马尔本杰明·莫尔
Owner UNIV OF MASSACHUSETTS